knowledge -WSS

knowledge

author：fashion 2025-09-07 21:55:08 - browse：6

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Akili changes sales model for its ADHD video game treatment

focus

WSS

Watch the official trailer for 'Ahsoka' series

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

FDA panel to weigh safety of artificial wombs for preterm births

EU fines Illumina $475 million over Grail acquisition

After half a century, Israel moves to evict squatter from his cave home on the beach

Akili changes sales model for its ADHD video game treatment

focus

knowledge

focus

After affirmative action ruling, medical educators look to 'holistic review'

FDA panel to weigh safety of artificial wombs for preterm births

What does generative AI mean for health care? We asked experts

Fed up with FDA, ALS advocates consider a take

Medicare proposal to cover medical devices draws a mixed reaction

PBMs drew scrutiny in House hearing — and so did pharma

Duchenne breakthrough therapy leaves behind pioneering families

Patients, doctors press FTC to beef up hospital merger scrutiny

Novavax promises a turnaround & Lilly roils the obesity market

Digital health funding stays low as a new reality sets in

hotspot

Why the quest to eradicate polio has stumbled

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

After half a century, Israel moves to evict squatter from his cave home on the beach

Vermont grapples with historic flooding as more rainstorms head for Northeast

Grad students accuse University of California of wage theft

Neurocrine congenital adrenal hyperplasia trial succeeds

Wikipedia

Wikipedia

focus

hotspot